INE901L01018
INE901L01018
ALEMBIC PHARMA LTD
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 |
|---|---|---|---|
Market & Enterprise Value | |||
Market Cap | 157.44B EUR | 161.81B EUR | 130.37B EUR |
Enterprise Value | 169.71B EUR | 161.81B EUR | 142.71B EUR |
Valuation Multiples | |||
Trailing P/E | 22.71x | 24.4x | 20.15x |
Forward P/E | 16.36x | -- | -- |
Price to Sales | 2.02x | 2.13x | 1.81x |
Price to Book | 2.77x | -- | 2.3x |
EV/Revenue | 2.18x | 2.13x | 1.98x |
EV/EBITDA | 14.96x | 13.53x | 12.58x |
Price to FCF (P/FCF) | -- | -- | -- |
EV/FCF | -- | -- | -- |
FCF Yield | -- | -- | -- |